10/16/2007 Memphis, TN staff CancerConsultants.com Researchers from MD Anderson have recommended vaccination of boys and girls against human papilloma virus (HPV) for prevention of squamous cell cancers of the head and neck (SCCHN) as well as for prevention of cervical cancer. The details of this study were reported in the October 1, 2007 issue of Cancer.[1] Human papilloma viruses are probably the sole cause of cancers of the cervix and have been associated with cancers of the vulva, vagina, penis and rectum. Epidemiologic and molecular biology studies have also suggested that HPV infection may be associated with cancers of the head and neck. The relationship between HPV infection and head and neck cancer was reviewed in 1998 by researchers from the University of North Carolina. They reported that the overall frequency of HPV in benign and precancerous lesions ranged from 18.5% to 35.9%, depending upon the detection methodology. Researchers affiliated with an international study have also reported that oral infection with human papilloma virus (HPV) is associated with the development of head and neck cancers. These authors concluded that HPV infection increased the risk of oropharyngeal cancer in alcohol and tobacco users and non-users. These authors also suggested that the more prevalent practice of oral sex may explain the increased incidence of tonsillar and base of the tongue cancers since 1973. Researchers involved in the current study documented the decline in SCCHN over the past 20 years due to the decline in smoking which began 40 years ago. They attribute [...]

10/15/2007 Memphis, TN staff CancerConsultants.com Infection with high-risk types of human papillomavirus (HPV) appears to contribute to the development of oropharyngeal cancer, and HPV vaccination of both boys and girls may reduce the occurrence of this disease. This was the conclusion of a review published in the journal Cancer. Oropharyngeal cancer is a type of head and neck cancer. The oropharynx is the part of the throat that includes the soft palate, the base of the tongue, and the tonsils. Exposures that are known to increase the risk of oropharyngeal cancer include tobacco and alcohol use. Research has also suggested that infection with certain types of human papillomavirus (HPV) may also play a role. Human papillomaviruses (HPV) consist of more than 100 different viruses. Some types of HPV cause warts on the hands or feet; others cause genital warts; and some have been linked with cancer, most notably cervical cancer. The types of HPV that account for a majority of cases of cervical cancer are HPV 16 and HPV 18. Vaccines that prevent infection with high-risk types of HPV have the potential to greatly reduce the occurrence of cervical cancer as well as other HPV-related cancers. The HPV vaccine that is currently on the market is Gardasil®, which targets HPV types 6 and 11 (which are linked with genital warts) as well as the cancer-associated types 16 and 18. The vaccine is approved for use in girls and women between the ages of nine and 26 years. To build the [...]

10/15/2007 New York, NY Denise Grady New York TImes Death rates from cancer have been dropping by an average of 2.1 percent a year recently in the United States, a near doubling of decreases that began in 1993, researchers are reporting. “Every 1 percent is 5,000 people who aren’t dying,” said Dr. Richard L. Schilsky, a professor of medicine at the University of Chicago and president-elect of the American Society of Clinical Oncology. “That’s a huge sense of progress at this point.” Much of the progress comes not from miracle cures, but from more mundane improvements in prevention, early detection and treatment of some of the leading causes of cancer death — lung, colorectal, breast and prostate tumors. Years of nagging and pleading by health officials are finally beginning to pay off, experts say, in smoking cessation and increased use of mammograms, colonoscopies and other screening tests for colorectal and prostate cancer. But the new statistics also contain bad news: American Indians and Alaska Natives in some regions are not benefiting from the same improvements as the rest of the population and have higher rates of preventable cancers and late-stage tumors that would have had a better prognosis had they been detected sooner. Some groups within those populations have high rates of smoking. Researchers attribute the problems to poverty, lower education levels and lack of insurance and access to medical care. About 1.8 million of the 3.3 million American Indians and Alaska Natives receive their medical care through the Indian [...]

10/12/2007 web-based article Peter Kessler et al Science Direct (sciencedirect.com) Introduction: Recently new concepts for the treatment of oral squamous cell carcinomas (SCC) have been developed, which include preoperative simultaneous neoadjuvant radiochemotherapy (RCT) and one stage operation with excision of the tumour and reconstruction. When we consider long-term survival, we find substantial evidence that combined treatment based on neoadjuvant radiochemotherapy is superior to adjuvant treatment including operation and postoperative radiation. Patients and methods: We studied two groups consisting of 74 patients given neoadjuvant treatment and 54 treated surgically. Ninety-nine patients suffered from stage III and IV diseases according to the UICC-criteria. Long-term survival was estimated by the Kaplan–Meier method. Results: Neoadjuvant treatment increased the prospect of a long-term survival free of tumour. Kaplan–Meier curves estimated a 5-year tumour-free survival in oral squamous cell carcinoma category T1 as 83% in the neoadjuvant group and 70% in the adjuvant group; the corresponding figures for T2 were 79% and 57%, for T3 68% and 33% and for T4 51% and 30%, respectively. The difference for T1, T2 and T4 tumours were significant. The preoperative radio- and chemotherapy were shown to be effective by the fact that pathohistologically resection specimens were free of tumour in 28 patients in the neoadjuvant group. Four patients died during the preoperative combination treatment. Of the patients, 65% in the adjuvant group and 72% in the neoadjuvant group survived the observation period. Conclusion: The neoadjuvant treatment results in better 5-year-survival rate than adjuvant treatment. Authors: Peter Kessler(a), Gerhard Grabenbauer(b), [...]

10/12/2007 Bangalore, India Bijoy Koyitty Reuters.com CuraGen Corp said it would discontinue the development of its oral mucositis drug candidate, velafermin, after a mid-stage trial failed to meet its main goal. CuraGen shares fell about 35 percent to 94 cents in morning trade Thursday on the Nasdaq. The primary endpoint was a decrease in the incidence of severe oral mucositis in patients receiving a single dose of velafermin compared to placebo, the biopharmaceutical company said in a statement. Oral mucositis is a common side effect of certain types of cancer therapy. The company said it would now continue to focus on belinostat, its drug candidate used to treat solid tumors and hematologic malignancies.

10/12/2007 Memphis, TN staff DentalEconomics (www.dentaleconomics.com) A case report published in Clinical Implant Dentistry and Related Research showed that hyperbaric oxygenation therapy could improve the success of dental implant treatment in patients who have undergone radiation treatments. Hyperbaric oxygen therapy is a method of delivering high concentration of oxygen to the body. A side effect of radiation treatment is reduced blood supply, resulting in lower oxygen levels in the areas receiving radiation. This leads to problems with the healing of bones and tissues, and can possibly lead to bone death. Thus, surgical procedures such as dental implantation can be very risky. The case report described a 45-year-old patient who wanted dental implants five years following radiation treatments for head and neck cancer. The patient received HBO treatments before and after implantation surgery. These treatments resulted in a successful implant, without complications such as infection or rejection. This case report shows that HBO treatments in disease-free patients can result in successful dental restoration. Such restoration can greatly improve the patient's quality of life.

10/11/2007 India Sanchita Sharma, Hindustan Times (www.hindustantimes.com) Buying cigarettes may not be a pleasant experience from December 1 as grim pictures of cancerous tumours or an ailing infant will be printed on the packet of your favourite brand. Despite pressure from the bidi and gutkha industries, the pictures have been included as part of a government campaign against tobacco. They will be used on packets of all tobacco products. “The revised Packaging and Labelling Rules, 2007, have been notified for the smoking and non-smoking forms of tobacco,” said Health Minister Anbumani Ramadoss. Following recommendations from a group of ministers – Pranab Mukherjee, Priya Ranjan Das Munshi, Oscar Fernandes, Kamal Nath, Jaipal Reddy and Ramadoss himself made up the panel – set up to review the “merits and demerits” of pictorial warnings, the skull-and-crossbones sign was dropped as also was the idea to give a picture of a dead body. These were found too offensive. A tobacco product will now carry the warning “tobacco kills” along with a picture that shows one of the following - smoking causes cancer, your smoking kills babies, tobacco causes painful death and tobacco causes mouth cancer. Over 250 million people in the country use tobacco products like gutka, cigarettes and bidis. Tobacco kills at least 10 lakh people in India every year, said the Indian Council of Medical Research. One in two Indian men and one in seven women uses tobacco, which causes 40 per cent of all cancers. "Pictures definitely have an impact. Pictorial [...]

10/11/2007 New York, NY Alex Berenson New York Times For American dentists, times have never been better. The same cannot be said for Americans’ teeth. With dentists’ fees rising far faster than inflation and more than 100 million people lacking dental insurance, the percentage of Americans with untreated cavities began rising this decade, reversing a half-century trend of improvement in dental health. Previously unreleased figures from the Centers for Disease Control and Prevention show that in 2003 and 2004, the most recent years with data available, 27 percent of children and 29 percent of adults had cavities going untreated. The level of untreated decay was the highest since the late 1980s and significantly higher than that found in a survey from 1999 to 2002. Despite the rise in dental problems, state boards of dentists and the American Dental Association, the main lobbying group for dentists, have fought efforts to use dental hygienists and other non-dentists to provide basic care to people who do not have access to dentists. For middle-class and wealthy Americans, straight white teeth are still a virtual birthright. And dentists say that a majority of people in this country receive high-quality care. But many poor and lower-middle-class families do not receive adequate care, in part because most dentists want customers who can pay cash or have private insurance, and they do not accept Medicaid patients. As a result, publicly supported dental clinics have months-long waiting lists even for people who need major surgery for decayed teeth. At [...]

10/10/2007 London, England Susie Rushton The Independent (news.independentco.uk) Tobacco pouches deliver a nicotine hit without the fumes. The Swedes swear by them – now they're coming here. Are they safe? "Give up" has been the medical advice to smokers since the early 1960s. But to help the millions of nicotine addicts in the UK who just can't quit tobacco even if it means a winter spent shivering outside both pub and office, health professionals may soon be offering a compromise: try snusing. Hailing from Sweden, snus (it rhymes with "loose") is a moist tobacco that comes in small brown pouches that are tucked under the top lip to deliver a hit of nicotine orally. Its name is a Swedish translation of "snuff", and it is developed from the powdered tobacco of the same name that found its way up the nostrils of all self-respecting courtiers back in the 18th century. It is currently banned in the UK and every EU member state apart from Sweden – which has the lowest cancer rates and fewest smokers in Europe. But its prohibition may soon be over: public health experts here are saying it may be a less dangerous alternative for the heaviest smokers. Last week, in a report by the Royal College of Physicians on how oral forms of nicotine might help to wean the most addicted smokers off cigarettes, snus was singled out as a potentially useful cessation aid. "There's no question that snus is much safer than smoking," says Professor [...]